MEDICINA
Departamento
Pfizer (United States)
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Pfizer (United States) (3)
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539
2009
-
Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH
European Journal of Endocrinology, Vol. 161, Núm. 4, pp. 533-540
2005
-
Doxazosin GITS versus standard doxazosin in mild to moderate hypertension
International Journal of Cardiology, Vol. 101, Núm. 1, pp. 97-104